Ronald W Penczek
CIK 1659075 · CAO & Controller · last filed 2026-06-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ANTM price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
INDIANAPOLIS, IN 46204
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ELV | CAO & Controller | 3,740 | $434.13 | $1.62M | -$1.94M | 10 | 2026-06-15 |
| Elevance Health, Inc. (ANTM) Delisted | CAO & Controller | 3,204 | $482.58 | $1.55M | -$4.90M | 13 | 2022-03-03 |
| ANTX | SVP, Chief Accounting Officer | 2,894 | $3.60 | $10.4K | -$1.34M | 10 | 2018-03-09 |
Recent Filings · Page 3 of 4
38 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-03-03 | Elevance Health, Inc. (ANTM) Delisted | Mixed | +2,035 | -$267.9K | EDGAR |
| 2020-11-10 | Elevance Health, Inc. (ANTM) Delisted | Sell (S) | −1,199 | -$396.6K | EDGAR |
| 2020-06-10 | Elevance Health, Inc. (ANTM) Delisted | Sell (S) | −545 | -$162.3K | EDGAR |
| 2020-03-04 | Elevance Health, Inc. (ANTM) Delisted | Mixed | +2,975 | -$386.3K | EDGAR |
| 2019-11-14 | Elevance Health, Inc. (ANTM) Delisted | Mixed | — | -$85.9K | EDGAR |
| 2019-05-31 | Elevance Health, Inc. (ANTM) Delisted | Mixed | — | -$99.8K | EDGAR |
| 2019-03-05 | Elevance Health, Inc. (ANTM) Delisted | Mixed | +1,010 | -$157.5K | EDGAR |
| 2018-09-06 | Elevance Health, Inc. (ANTM) Delisted | Mixed | — | -$89.5K | EDGAR |
| 2018-03-09 | ANTX | Mixed | −987 | -$311.1K | EDGAR |
| 2018-03-05 | ANTX | Mixed | +910 | -$100.1K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.